Eiger BioPharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 1.48M shares, a 6.39% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.48M shares, a 6.39% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.39M shares, a 95.9% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 33.9M shares, a 20.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 1.48M +88.6K +6.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-08
Q3 2023 44.3M +310K +0.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 44.3M +1.24M +2.87% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 44.1M +8.89M +25.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.39M -32.6M -95.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 44M +10.1M +29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 43.1M +9.13M +26.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 35.3M +1.37M +4.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 33.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 33.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 33.9M +8.43M +33.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 33.9M +9.39M +38.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q2 2020 25.5M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 24.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.